Stay updated on Nemolizumab in Adolescent AD: Pharmacokinetics and Safety Clinical Trial
Sign up to get notified when there's something new on the Nemolizumab in Adolescent AD: Pharmacokinetics and Safety Clinical Trial page.

Latest updates to the Nemolizumab in Adolescent AD: Pharmacokinetics and Safety Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoChange DetectedThe revision label in the page footer updated from v3.5.2 to v3.5.3, indicating a version bump for the site's software.SummaryDifference0.0%

- Check15 days agoNo Change Detected
- Check23 days agoChange DetectedRevision label updated from v3.5.0 to v3.5.2 on the page.SummaryDifference0.0%

- Check51 days agoChange DetectedRevision updated from v3.4.3 to v3.5.0 on the page.SummaryDifference0.0%

- Check58 days agoChange DetectedRevision updated from v3.4.2 to v3.4.3. This is a minor update with no substantive changes to the page content.SummaryDifference0.0%

- Check87 days agoChange DetectedA new site revision (Revision: v3.4.2) was added and an older funding-status notice along with Revision: v3.4.1 were removed; these changes are administrative and do not affect the study details or content.SummaryDifference0.4%

- Check94 days agoChange DetectedA new notice about a lapse in government funding was added and the site version updated to v3.4.1; the previous version reference v3.4.0 was removed.SummaryDifference0.4%

Stay in the know with updates to Nemolizumab in Adolescent AD: Pharmacokinetics and Safety Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nemolizumab in Adolescent AD: Pharmacokinetics and Safety Clinical Trial page.